Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

On March 7, 2023, when the Goddess Day was coming, Pioneer Pharmaceutical welcomed the entrepreneurs from the fourth class committee of the 39th issue of Cheung Kong Graduate School of Business to visit Pioneer for guidance!

2023-05-25

In 2023, the R&D department will relax --- Spring Festival exercise (1)

When the flowers are in full bloom, they are filled with the mood of harvest, and they are burdened with the confusion of the bottleneck...

2023-04-15

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

On March 7, 2023, when Goddess Day is approaching, Pioneer Pharmaceuticals welcomes entrepreneur friends from the fourth class committee of the 39th Cheung Kong Graduate School of Business to come to Pioneer to guide the work!

2023-03-08

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

On the occasion of the New Year's Day in 2023 , Anhui Pioneer Pharmaceutical Co., Ltd. received two notices of approval for registration of generic drugs issued by the State Food and Drug Administration. The approved product is Clindamycin Phosphate Injection (Trademark: Xinruijia® ) with specifications of 2ml  :0.3g and 4ml:0.6g ), and the approval numbers are Guoyao Zhunzi H20223952 and Guoyao Zhunzi H20223953 respectively . At the beginning of the new year, Pioneer Pharmaceuticals successfully obtained 2 R&D achievements, which will definitely have far-reaching significance for the long-term development of the company!

2023-02-27

Congratulations to Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

On the arrival of the New Year's Day in 2023, Anhui Pioneer Pharmaceutical Co., Ltd. received two notices of approval for the application and registration of generic drugs issued by the State Food and Drug Administration.

2023-02-27

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

On February 24, 2023, Anhui Pioneer Pharmaceutical Co., Ltd. (hereinafter referred to as "Pioneer Pharmaceutical") ushered in the approval and issuance of the approval document for the consistency evaluation of generic drugs this year. The State Drug Administration approved and issued the "Drug Supplementary Application Approval Document", officially notifying Anhui Pioneer Pharmaceuticals that "Fenofibrate Capsules" is the first to pass the consistency evaluation of generic drug quality and efficacy!

2023-02-25

Building standards and norms suitable for IT service operations in China with SPS as the core

Technological innovation is the key to core competitiveness. China Digital has built a strong information technology research and operation team, with nearly 2000 software research and development personnel. It is the chairman unit of the "Changfeng Alliance Internet Information Service Industry Promotion Working Group" of the Ministry of Science and Technology, truly proposing a SaaS service system with Chinese characteristics, with SPS as the core to build standards and norms suitable for China's IT service operation. In terms of ICT infrastructure construction, China Digital has established professional data centers in Beijing, Guangzhou, Suzhou, and other places, achieving interconnection between North and South Telecom, and building a highly secure and reliable network environment with over 3000 operational equipment; By establishing joint laboratories with companies such as NetApp and HP, computing pooling and storage pooling have been achieved; In the field of e-commerce, we have pioneered the development of an on-demand and personalized e-commerce platform. We have applied for more than ten technical patents and become a pilot enterprise for patent engines in Beijing.

2021-11-09

What are the main responsibilities of drug production technology

Drug production technology mainly studies basic knowledge and skills in drug production, drug testing, and drug marketing, and conducts drug synthesis and processing, process control, production management, quality testing, and marketing. For example: production and testing of vaccines, protein and nucleic acid drugs, identification of animal Chinese medicines, mineral Chinese medicines, and proprietary Chinese medicines, drug development and marketing, etc.

2021-07-19

The Relationship between Various Entities in the Pharmaceutical Industry Chain - Production and MAH System

The Drug Marketing Authorization Holder (Marketing Authorization Holder, MAH) system is closely related to the production of drugs. In the MAH system, the holder refers to the company or drug research and development institution that has obtained the drug registration certificate. The MAH can be a domestic company or an overseas company. , the system separates the production license from the marketing license, and the holder can produce drugs by itself, or entrust domestic and foreign drug manufacturers to produce. However, in principle, blood products, narcotic drugs, psychotropic drugs, toxic drugs for medical use, and pharmaceutical precursor chemicals are not allowed to be commissioned for production.

2021-03-10

Cooperation in the field of big health

On Wednesday, September 23, 2020, cooperative customers in the field of general health visited Pioneer, accompanied by Chairman Chen Dong, Vice President of Sales He Chuanlan, Sales Director Gao Lixia, Marketing Director Li Xiaobao, etc. Customers have fully recognized Pioneer's product technology and quality standard system, as well as the after-sales system. In the later stage, we will explore new models together and strengthen cooperation.

2020-09-24